查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495439

冠狀動脈疾病市場：按類型、最終用戶分類 - 2024-2030 年全球預測

Coronary Artery Disease Market by Type (Diagnostics, Treatment), End-User (Ambulatory Surgery Centers, Diagnostic Centers, Hospitals & Clinics) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年冠心病市場規模為118.8億美元，預計2024年將達125.3億美元，2030年將達174.9億美元，複合年成長率為5.68%。

冠狀動脈疾病 (CAD) 是一種以冠狀動脈阻塞或狹窄為特徵的疾病，冠狀動脈是向心臟供應氧氣和營養的主要血管。這種疾病主要是由動脈壁上的斑塊堆積引起的，斑塊由脂肪、膽固醇和其他物質組成。這種積聚會限制流向心臟的血液，導致胸痛等症狀，嚴重時還會導致心臟病發作。導致 CAD 傳播的主要因素包括人口老化以及肥胖、糖尿病、不良飲食、缺乏運動和吸煙等生活方式相關風​​險的增加。然而，先進治療設備的高成本以及與 CAD 設備相關的產品召回問題正在阻礙市場成長。儘管存在這些挑戰，個人化醫療和新型治療方法的持續努力預計將提供量身定做的治療方案並減輕這種疾病的整體負擔。

主要市場統計
基準年[2023] 118.8億美元
預測年份 [2024] 125.3億美元
預測年份 [2030] 174.9億美元
複合年成長率（%） 5.68%

區域洞察

美洲，尤其是美國，由於先進的醫療基礎設施和 CAD 的高盛行率而呈現強勁的市場成長，增加了對先進治療的需求。此外，對醫療保健的大量投資和對冠狀動脈疾病的高度認知正在推動該地區的市場。歐洲展示了強大的醫療保健系統和強力的法律規範，支持 CAD 的有效管理。在中東和非洲，醫療發展和 CAD 意識的提高正在推動市場成長。在中國和印度等人口大國醫療保健支出增加以及對心血管疾病意識提高的推動下，亞太地區 CAD 市場正在快速成長。此外，醫療保健基礎設施的改善和中階的不斷壯大也促進了對心臟病治療的更多關注和市場擴張。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在冠狀動脈疾病市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對冠狀動脈疾病市場中供應商的現狀進行深入而詳細的評估。對供應商貢獻的徹底比較和分析可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在冠狀動脈疾病市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化導致冠心病發病率增加
      • 由於醫療基礎設施投資增加而擴大醫療基礎設施
    • 抑制因素
      • 深度處理設備高成本，先進技術商業化受到限制
    • 機會
      • CAD 管理產品的進步與改進
      • 持續擴大微創手術和手術中心
    • 任務
      • 因安全問題而涉及產品召回的問題
  • 市場區隔分析
    • 類型：對手術的需求不斷增加，以有效管理 CAD 並提高生活品質
    • 最終使用者：高度偏好提供全面 CAD 照護的醫院和診所
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 冠狀動脈疾病市場：依類型

  • 診斷
  • 治療

第7章 冠狀動脈疾病市場：依最終使用者分類

  • 門診手術中心
  • 診斷中心
  • 醫院/診所

第8章美洲冠狀動脈疾病市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區冠心病市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的冠心病市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Abbott 推出改良的 Xience Sierra 支架系統以改善心臟治療
    • 創新Start-Ups利用人工智慧技術徹底改變冠狀動脈疾病檢測
  • 戰略分析和建議

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-5D693B46C822

[194 Pages Report] The Coronary Artery Disease Market size was estimated at USD 11.88 billion in 2023 and expected to reach USD 12.53 billion in 2024, at a CAGR 5.68% to reach USD 17.49 billion by 2030.

Coronary artery disease (CAD) is a medical condition characterized by the blockage or narrowing of coronary arteries, which are major blood vessels supplying oxygen and nutrients to the heart. This disease is primarily caused by the buildup of plaque, a combination of fat, cholesterol, and other substances in the artery walls. This buildup restricts the blood flow to the heart, leading to symptoms, including chest pain and, in severe cases, heart attacks. The major factors that contribute to the expansion of CAD include an aging population and increased prevalence of lifestyle-related risks such as obesity, diabetes, poor diet, physical inactivity, and smoking. However, the high costs of advanced therapeutic devices and product recall issues associated with CAD devices hinder market growth. Despite these issues, growing initiatives in personalized medicine and new therapeutic approaches are expected to provide tailored treatment options, reducing the overall burden of the disease.

KEY MARKET STATISTICS
Base Year [2023] USD 11.88 billion
Estimated Year [2024] USD 12.53 billion
Forecast Year [2030] USD 17.49 billion
CAGR (%) 5.68%

Regional Insights

The Americas, particularly the United States, shows strong market growth owing to advanced healthcare infrastructure and a high prevalence of CAD, raising the need for advanced treatments. Additionally, significant investment in healthcare and high awareness about coronary artery disease drives the market in the region. Europe exhibits a robust healthcare system and strong regulatory frameworks that aid in the effective management of CAD. In the Middle East and Africa, the market in this region is growing, driven by increasing healthcare development and rising awareness of CAD. Asia-Pacific is experiencing rapid growth in the CAD market, propelled by increasing healthcare expenditure and growing awareness of cardiovascular diseases in populous countries, including China and India. Further, improvements in healthcare infrastructure and the rising middle class are contributing to a stronger focus on heart disease treatments and an expanding market.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Coronary Artery Disease Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising incidences of coronary artery disease due to aging populations
      • Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
    • Market Restraints
      • High cost of advanced therapeutic devices and limited commercialization of advanced technologies
    • Market Opportunities
      • Advancements and improvements in CAD management products
      • Continuous expansion of minimally invasive procedures and surgery centers
    • Market Challenges
      • Problems associated with product recalls due to safety concerns
  • Market Segmentation Analysis
    • Type: Growing need for surgeries to manage CAD effectively and improve the quality of life
    • End-User: Higher preferences for hospitals and clinics that offer integrated CAD care
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Coronary Artery Disease Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Coronary Artery Disease Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Abbott Introduces Enhanced Xience Sierra Stent System for Improved Cardiac Care

Abbott Laboratories unveiled the Xience Sierra coronary stent system, which is designed to assist patients suffering from coronary artery disease. The newly launched stent system represents an advancement in the treatment of heart ailments by offering greater flexibility and a wider range of sizes compared to previous models. This innovation aims to cater to complex and challenging anatomies, thereby potentially increasing the success rates of angioplasty procedures. [Published On: 2024-05-03]

Innovative Startup Revolutionizes Coronary Artery Disease Detection with AI Technology

Genexia has developed a cutting-edge artificial intelligence (AI) system aimed at improving the diagnosis of coronary artery disease (CAD). This AI tool integrates seamlessly with existing medical imaging technologies to analyze cardiovascular images with heightened accuracy and speed, thereby facilitating earlier and more precise diagnoses of CAD. The technology promises to enhance patient outcomes by enabling timely medical intervention and stands to significantly reduce the workload of cardiologists by automating complex diagnostic processes. Th [Published On: 2024-02-09]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Coronary Artery Disease Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Coronary Artery Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences, FUJIFILM Holdings Corporation, GE HealthCare Technologies, Inc., Genesee Biomedical Inc., Getinge AB, Hitachi, Ltd., Koninklijke Philips N.V., Medtronic PLC, Merck KGaA, MicroPort Scientific Corporation, Siemens Healthineer AG, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Diagnostics
      • Cardiac Catheterization & Angiogram
      • Echocardiogram
      • Electrocardiogram
      • Exercise Stress Test
      • Heart CT Scan
      • Nuclear Stress Test
    • Treatment
      • Medications
        • Angiotensin-converting Enzyme Inhibitors & Angiotensin II Receptor Blockers Nitroglycerin
        • Aspirin
        • Beta-blockers
        • Calcium Channel Blockers
        • Cholesterol Drugs
        • Ranolazine
      • Surgeries
        • Coronary Angioplasty & Stent Placement
        • Coronary Artery Bypass Graft Surgery
  • End-User
    • Ambulatory Surgery Centers
    • Diagnostic Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of coronary artery disease due to aging populations
      • 5.1.1.2. Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced therapeutic devices and limited commercialization of advanced technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CAD management products
      • 5.1.3.2. Continuous expansion of minimally invasive procedures and surgery centers
    • 5.1.4. Challenges
      • 5.1.4.1. Problems associated with product recalls due to safety concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing need for surgeries to manage CAD effectively and improve the quality of life
    • 5.2.2. End-User: Higher preferences for hospitals and clinics that offer integrated CAD care
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Coronary Artery Disease Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostics
  • 6.3. Treatment

7. Coronary Artery Disease Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Diagnostic Centers
  • 7.4. Hospitals & Clinics

8. Americas Coronary Artery Disease Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Coronary Artery Disease Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Coronary Artery Disease Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Abbott Introduces Enhanced Xience Sierra Stent System for Improved Cardiac Care
    • 11.3.2. Innovative Startup Revolutionizes Coronary Artery Disease Detection with AI Technology
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CORONARY ARTERY DISEASE MARKET RESEARCH PROCESS
  • FIGURE 2. CORONARY ARTERY DISEASE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CORONARY ARTERY DISEASE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. CORONARY ARTERY DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. CORONARY ARTERY DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIAC CATHETERIZATION & ANGIOGRAM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIAC CATHETERIZATION & ANGIOGRAM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EXERCISE STRESS TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EXERCISE STRESS TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HEART CT SCAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HEART CT SCAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY NUCLEAR STRESS TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY NUCLEAR STRESS TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS & ANGIOTENSIN II RECEPTOR BLOCKERS NITROGLYCERIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS & ANGIOTENSIN II RECEPTOR BLOCKERS NITROGLYCERIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ASPIRIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CHOLESTEROL DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CHOLESTEROL DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY RANOLAZINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY RANOLAZINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ANGIOPLASTY & STENT PLACEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ANGIOPLASTY & STENT PLACEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2024-2030 (USD MILLION)
  • TABLE 331. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND CORONARY ARTERY D